AU3863997A - Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution - Google Patents
Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solutionInfo
- Publication number
- AU3863997A AU3863997A AU38639/97A AU3863997A AU3863997A AU 3863997 A AU3863997 A AU 3863997A AU 38639/97 A AU38639/97 A AU 38639/97A AU 3863997 A AU3863997 A AU 3863997A AU 3863997 A AU3863997 A AU 3863997A
- Authority
- AU
- Australia
- Prior art keywords
- diarrhoea
- swallowed
- foods
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM96A0571 | 1996-08-09 | ||
IT96RM000571A IT1284877B1 (en) | 1996-08-09 | 1996-08-09 | TREATMENT OF ACUTE DIARRHEA IN CHILDREN AND PREVENTION OF ALLERGIC SENSITIZATION TO FOODS INTRODUCED DURING THE PHASE |
PCT/IT1997/000201 WO1998006411A2 (en) | 1996-08-09 | 1997-08-04 | Use of lactobacillus gg in the rehydrating solution |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3863997A true AU3863997A (en) | 1998-03-06 |
Family
ID=11404390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU38639/97A Abandoned AU3863997A (en) | 1996-08-09 | 1997-08-04 | Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0918531A2 (en) |
AU (1) | AU3863997A (en) |
IT (1) | IT1284877B1 (en) |
WO (1) | WO1998006411A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2785809B1 (en) | 1998-11-18 | 2001-01-12 | Gervais Danone Sa | SELECTION AND USES OF STRAINS OF LACTIC BACTERIA MODULATING NON-SPECIFIC IMMUNITY |
EP1034787A1 (en) | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactobacillus strains preventing diarrhea caused by pathogenic bacteria |
US6887465B1 (en) * | 1999-03-11 | 2005-05-03 | Nestec S.A. | Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses |
EP1034788A1 (en) * | 1999-03-11 | 2000-09-13 | Société des Produits Nestlé S.A. | Lactic acid bacteria strains capable of preventing diarrhea |
BR0111584A (en) * | 2000-06-13 | 2003-05-06 | Unilever Nv | Method for the production of a food product comprising non-viable lactobacillus bacteria, and, food product |
ES2277550B1 (en) * | 2005-12-21 | 2008-06-16 | Laboratorios Casen-Fleet, S.L. | PHARMACEUTICAL KIT FOR THE PREPARATION OF A HYDRATION SALT WITH A BABY PROBIOTIC. |
EP2455094A1 (en) | 2010-11-11 | 2012-05-23 | Nestec S.A. | Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
AU624067B2 (en) * | 1986-12-12 | 1992-06-04 | Biorem C.C. | Preparation suitable for use in the treatment of enteric disorders |
CA2081388A1 (en) * | 1990-04-09 | 1991-10-10 | Jonah Shacknai | Antidiarrheal composition and method |
US5413785A (en) * | 1993-01-27 | 1995-05-09 | New England Deaconess Hospital Corp. | Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo |
CA2156859A1 (en) * | 1993-02-24 | 1994-09-01 | Sherwood L. Gorbach | Method of enhancing immune response to oral vaccines |
-
1996
- 1996-08-09 IT IT96RM000571A patent/IT1284877B1/en active IP Right Grant
-
1997
- 1997-08-04 EP EP97935765A patent/EP0918531A2/en not_active Withdrawn
- 1997-08-04 WO PCT/IT1997/000201 patent/WO1998006411A2/en not_active Application Discontinuation
- 1997-08-04 AU AU38639/97A patent/AU3863997A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0918531A2 (en) | 1999-06-02 |
ITRM960571A1 (en) | 1998-02-09 |
WO1998006411A3 (en) | 1998-05-07 |
WO1998006411A2 (en) | 1998-02-19 |
ITRM960571A0 (en) | 1996-08-09 |
IT1284877B1 (en) | 1998-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5844598A (en) | Improvements relating to hygiene and medical products | |
CA2229624A1 (en) | Method of reducing bodyweight and treating obesity | |
IL107518A0 (en) | Therapeutic and diagnostic compositions comprising purified surface modifiers to prevent particle aggregation during sterilization | |
CA2294099A1 (en) | Absorption of minerals | |
AU2249892A (en) | Diagnosis and treatment of arterial chlamydial granuloma | |
ZA899176B (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment | |
AU1937395A (en) | Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic | |
GR3019625T3 (en) | Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment | |
IL130784A0 (en) | Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same | |
AU2300001A (en) | Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease | |
AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
AU1492401A (en) | Cleanser that is gentle to human skin | |
AU2463099A (en) | Gabapentin and its derivatives for the treatment of muscular and skeletal pain | |
AU5911994A (en) | Oral formulations of ubidecarenone in the form of capsules | |
WO2000074712A3 (en) | Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product | |
AU3863997A (en) | Treatment of the acute infant's diarrhoea and prevention of allergic reactions to foods swallowed in the following phase by administering lactobacillus gg in the oral rehydrating solution | |
HK1026637A1 (en) | Compositions for administering taxanes orally to human patients and their use | |
AU4210696A (en) | Use of AICA riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow | |
HUP9904294A3 (en) | Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain | |
AU2001282730A1 (en) | Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary andpara-alimentary (food-supplements) products; their methods of preparation; thei r uses as preventive and/or as therapeutic agents | |
GB9316615D0 (en) | Improvements in or relating to the ultrasonic detection of dental caries | |
ZA967319B (en) | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form | |
FR2685867B1 (en) | COMPOSITIONS AGAINST DEQUAMATION OF THE SKIN AND SCALP. | |
AU2742395A (en) | Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets | |
ZA944281B (en) | Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease |